Related Experiment Videos
Simulation as a design tool for phase I/II clinical trials: an example from bone marrow transplantation
T A Gooley1, P J Martin, L D Fisher
1Fred Hutchinson Cancer Research Center, Seattle, Washington 98104.
Controlled Clinical Trials
|December 1, 1994
Summary
This study introduces novel clinical trial designs for bone marrow transplantation, balancing risks of complications. Improved designs enhance safety and reduce erroneous conclusions in dose-finding studies.
Area of Science:
- Hematology
- Clinical Trial Design
- Biostatistics
Background:
- Bone marrow transplantation involves complex dose-finding challenges.
- Balancing competing risks of treatment complications is critical for patient safety.
Purpose of the Study:
- To design and analyze phase I/II clinical trials for bone marrow transplantation.
- To identify optimal dosing strategies that mitigate risks of treatment-related complications.
Main Methods:
- Simulation of three dose-response scenarios.
- Evaluation of operating characteristics for three sequentially developed trial designs.
- Comparative analysis of trial design performance.
Main Results:
- Initial trial design showed inadequate performance in simulations.
- Subsequent designs demonstrated improved risk-balancing capabilities.
- Risk of erroneous conclusions was significantly reduced with optimized designs.
Conclusions:
- Careful examination of operating characteristics is essential for effective clinical trial design.
- Optimized trial designs can improve safety and accuracy in bone marrow transplantation studies.
- The proposed designs offer a framework for managing competing risks in dose-finding trials.